Featured Publications*
View All
Clinical Cancer Research
Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer.
JAMA Oncology
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
New England Journal Of Medicine
Tepotinib in Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Clinical Lung Cancer
Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
Journal of Clinical Oncology
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis.
Case Studies
Advanced Breast Cancer
56-year-old female previously treated for early-stage breast cancer
Advanced CRC
63-year-old male referred to a large cancer center after metastases appeared
Advanced Lung Cancer
68-year-old male non-smoker who initially presented with severe cough and nausea

*Disclaimer: This content has not been reviewed by the FDA. Data shown for the performance of Guardant360® Laboratory Developed Test (LDT) does not convey the performance of Guardant360® CDx.